<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="jcmm15364-tbl-0001" xml:lang="en" content-type="Table" orientation="portrait" position="float">
 <label>Table 1</label>
 <caption>
  <p>The changes of nucleic acid test and serological test in the Diagnosis and Treatment Guideline of COVID‐19 from version 2 to 7 in China</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <thead valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="top" rowspan="1" colspan="1">Description</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Ver 7 (Mar 4)</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Ver 6 (Feb 18)</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Ver 5 (Feb 4)</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Ver 4 (Jan 27)</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Ver 3 (Jan 23)</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Ver 2 (Jan 18)</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">Laboratory test</td>
    <td align="left" rowspan="1" colspan="1">
     <p>
      <italic>1. Aetiological test: nucleic acid test in the specimens of pharyngeal swab, sputum and other lower respiratory tract secretions, blood, faeces by real‐time RT‐PCR and NGS.</italic>
     </p>
     <p>
      <italic>Sputum and lower respiratory tract secretions are more accurate;</italic>
     </p>
     <p>
      <italic>2. Serological test: novel coronavirus IgM antibody presents on the 3‐5 days after COVID‐19 onset, IgG antibody titre increases 4 times or more in recovery phase compared to acute phase.</italic>
     </p>
    </td>
    <td align="left" rowspan="1" colspan="1">Nucleic acid test in the specimens of pharyngeal swab, sputum and other lower respiratory tract secretions, blood. 
     <italic>To make sure the accurate result, recommend taking the sputum and secretions from the lower respiration track by tracheal</italic> intubation.
    </td>
    <td align="left" rowspan="1" colspan="1">Nucleic acid test in the specimens of pharyngeal swab, sputum and other lower respiratory tract secretions, blood and faeces.</td>
    <td align="left" rowspan="1" colspan="1">Nucleic acid test 
     <italic>in the specimens of pharyngeal swab, sputum and other lower respiratory tract secretions, blood.</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">NA</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Diagnosis confirmation</td>
    <td align="left" rowspan="1" colspan="1">
     <p>The suspected case, who have one of the following aetiological evidences:</p>
     <p>1.Nucleic acid test is positive by real‐time RT‐PCR.</p>
     <p>2.Have high identity with the known novel coronavirus sequence by NGS.</p>
     <p>
      <italic>3.Serological test: both the specific IgM and IgG antibody of SARS‐CoV‐2 are positive; serological IgG antibody becomes positive or IgG antibody titre increases 4 times or more in recovery phase compared to acute phase</italic>
     </p>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <p>The suspected case, who have one of the following aetiological evidences:</p>
     <p>1.Nucleic acid test is positive by real‐time RT‐PCR</p>
     <p>2.Have high identity with the known novel coronavirus sequence by NGS</p>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <p>The suspected case, who have one of the following aetiological evidences:</p>
     <p>1. Nucleic acid test is positive by real‐time RT‐PCR in the respiratory or blood specimens.</p>
     <p>2. Have high identity with the known novel coronavirus sequence by NGS in the respiratory or blood specimens</p>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <p>The suspected case, who have one of the following aetiological evidences:</p>
     <p>1. Nucleic acid test is positive by real‐time RT‐PCR 
      <italic>in the respiratory or blood specimens.</italic>
     </p>
     <p>2. Have high identity with the known novel coronavirus sequence by NGS 
      <italic>in the respiratory or blood specimens</italic>
     </p>
    </td>
    <td align="left" rowspan="1" colspan="1">No change</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Conform to the suspected case standard and have the following:</p>
     <p>1.Nucleic acid test is positive by real‐time RT‐PCR in the specimens of sputum, pharyngeal swab and lower respiratory tract secretions.</p>
     <p>2.Have high identity with the known novel coronavirus sequence by NGS in the specimens of sputum, pharyngeal swab and lower respiratory tract secretions</p>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Report system</td>
    <td align="left" rowspan="1" colspan="1">
     <p>
      <italic>The suspected case can be excluded if fitting for the following two conditions: 1. Nucleic acid test is negative in two consecutive times (the interval of sampling time is at least 24 h).</italic>
     </p>
     <p>
      <italic>2. And the specific IgM and IgG antibody of SARS‐CoV‐2 are negative after 7‐d onset</italic>
     </p>
    </td>
    <td align="left" rowspan="1" colspan="1">The suspected cases should be isolated and tested for nucleic acid of SARS‐CoV‐2</td>
    <td align="left" rowspan="1" colspan="1">No change</td>
    <td align="left" rowspan="1" colspan="1">No change</td>
    <td align="left" rowspan="1" colspan="1">No change</td>
    <td align="left" rowspan="1" colspan="1">The suspected cases should be isolated and introduced for multidiscipline diagnosis within 2h; If necessary, they should be tested for nucleic acid of SARS‐CoV‐2. The suspected case can be excluded if nucleic acid test is negative in two consecutive times (the interval of sampling time is at least 1 day).</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Release from quarantine</td>
    <td align="left" rowspan="1" colspan="1">
     <italic>The out‐of‐hospital standard: Nucleic acid test is negative in two consecutive times (the interval of sampling time is at least 24 h) in the specimens of sputum and respiratory tract secretion etc</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">No change</td>
    <td align="left" rowspan="1" colspan="1">No change</td>
    <td align="left" rowspan="1" colspan="1">No change</td>
    <td align="left" rowspan="1" colspan="1">No change</td>
    <td align="left" rowspan="1" colspan="1">The out‐of‐hospital standard: Nucleic acid test is negative in two consecutive times (the interval of sampling time is at least 1 d) in the respiratory tract specimens.</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot id="jcmm15364-ntgp-0001">
  <title>Note</title>
  <fn id="jcmm15364-note-0001">
   <p>The italicized text indicates the increased contents in the guideline compared with the previous version.</p>
  </fn>
 </table-wrap-foot>
 <permissions>
  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
 </permissions>
</table-wrap>
